BACKGROUND: The purpose of this study was to determine the feasibility of both lymphatic mapping and probe-guided primary tumor excision by use of intralesional tracer administration in clinically occult breast cancer. METHODS: Sixty patients with a clinically occult breast lesion were prospectively included. Lymphoscintigraphy was performed after intratumoral injection of 99mTc-labeled nanocolloid guided by ultrasound or stereotaxis. A catheter over a localization wire was inserted for intraoperative blue dye administration by using the same imaging techniques. After sentinel node identification, the gamma-ray detection probe was used for radio-guided wide local excision in patients who underwent breast-conserving therapy. RESULTS: A sentinel node was visualized on the scintigrams in 56 patients (93%) and could be identified intraoperatively in 58 patients (97%). A sentinel node contained tumor in 10 (17%) of these patients. Extra-axillary sentinel nodes were visualized in 43%, were collected in 38%, and contained metastasis in 7% of the patients. Complete excision of the primary tumor could be accomplished in 39 (87%) of 45 patients. CONCLUSIONS: Both sentinel node biopsy and probe-guided excision of a nonpalpable breast cancer is feasible with the aid of intralesional tracer administration. Sentinel node metastasis was found in 17% of the patients. A remarkably high percentage of extra-axillary drainage (43%) was observed.
BACKGROUND: The purpose of this study was to determine the feasibility of both lymphatic mapping and probe-guided primary tumor excision by use of intralesional tracer administration in clinically occult breast cancer. METHODS: Sixty patients with a clinically occult breast lesion were prospectively included. Lymphoscintigraphy was performed after intratumoral injection of 99mTc-labeled nanocolloid guided by ultrasound or stereotaxis. A catheter over a localization wire was inserted for intraoperative blue dye administration by using the same imaging techniques. After sentinel node identification, the gamma-ray detection probe was used for radio-guided wide local excision in patients who underwent breast-conserving therapy. RESULTS: A sentinel node was visualized on the scintigrams in 56 patients (93%) and could be identified intraoperatively in 58 patients (97%). A sentinel node contained tumor in 10 (17%) of these patients. Extra-axillary sentinel nodes were visualized in 43%, were collected in 38%, and contained metastasis in 7% of the patients. Complete excision of the primary tumor could be accomplished in 39 (87%) of 45 patients. CONCLUSIONS: Both sentinel node biopsy and probe-guided excision of a nonpalpable breast cancer is feasible with the aid of intralesional tracer administration. Sentinel node metastasis was found in 17% of the patients. A remarkably high percentage of extra-axillary drainage (43%) was observed.
Authors: Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin Journal: World J Surg Oncol Date: 2009-01-27 Impact factor: 2.754
Authors: Susanne H Estourgie; Omgo E Nieweg; Renato A Valdés Olmos; Emiel J Th Rutgers; Bin B R Kroon Journal: Ann Surg Date: 2004-02 Impact factor: 12.969
Authors: Marcos Fernando de Lima Docema; Paulo Aguirre Costa; Felipe Eduardo Martins de Andrade; Jose Luiz Barbosa Bevilacqua; Simone Elias; Giovanni Guido Cerri; Alfredo Carlos S D Barros; Afonso Celso Pinto Nazario Journal: World J Surg Oncol Date: 2014-10-23 Impact factor: 2.754
Authors: S van Esser; M Hobbelink; J W Van Isselt; W P Th M Mali; I H M Borel Rinkes; R van Hillegersberg Journal: Eur J Nucl Med Mol Imaging Date: 2009-03-25 Impact factor: 9.236
Authors: Stijn van Esser; Monique G G Hobbelink; Petra H M Peeters; Erik Buskens; Iris M van der Ploeg; Willem P T H M Mali; Inne H M Borel Rinkes; Richard van Hillegersberg Journal: BMC Surg Date: 2008-05-21 Impact factor: 2.102
Authors: Giulia Anna Follacchio; Francesco Monteleone; Paolo Anibaldi; Giuseppe De Vincentis; Silvia Iacobelli; Raffaele Merola; Valerio D'Orazi; Massimo Monti; Vittorio Pasta Journal: J Exp Clin Cancer Res Date: 2015-10-06
Authors: Bas Pouw; Linda J de Wit-van der Veen; Daan Hellingman; Oscar R Brouwer; Marie-Jeanne Tfd Vrancken Peeters; Marcel Pm Stokkel; Renato A Valdés Olmos Journal: EJNMMI Res Date: 2014-05-03 Impact factor: 3.138